NON-INVASIVE RISK STRATIFICATION IN METABOLIC DYSFUNCTION-ASSOCIATED STEATOTIC LIVER DISEASE: INTEGRATING FIBROSIS AND KIDNEY RISK
The available evidence regarding sequential non-invasive fibrosis assessment and a liver-kidney risk-stratification strategy that could be integrated for general clinical practice are reviewed to suggest a liver-kidney risk-stratification strategy that could be integrated for general clinical practice.